189 related articles for article (PubMed ID: 456507)
21. [Biologic availability and pharmacokinetics in laboratory animals].
Tamassia V
Boll Chim Farm; 1973 May; 112(5):291-300. PubMed ID: 4761106
[No Abstract] [Full Text] [Related]
22. Theory and practice of prodrug kinetics.
Notari RE
Methods Enzymol; 1985; 112():309-23. PubMed ID: 4046852
[No Abstract] [Full Text] [Related]
23. [Biopharmaceutic and pharmacokinetic parameters in assessing pharmacopoeial drug quality standards (author's transl)].
Zathurecký L
Cas Lek Cesk; 1977 Apr; 116(16):481-5. PubMed ID: 872171
[No Abstract] [Full Text] [Related]
24. Prodrug lability prediction through the use of substituent effects.
Charton M
Methods Enzymol; 1985; 112():323-40. PubMed ID: 4046853
[No Abstract] [Full Text] [Related]
25. [Pediatric pharmacology. Practical ideas of kinetics and metabolism of drugs].
Royer RJ
Arch Fr Pediatr; 1976 Apr; 33(4):401-7. PubMed ID: 952595
[TBL] [Abstract][Full Text] [Related]
26. [Clinical value of the determination of drugs in the blood: a new aspect of pharmacokinetics].
Hirtz J; Schoeller JP
Nouv Presse Med; 1976 Mar; 5(13):869-72. PubMed ID: 1264634
[No Abstract] [Full Text] [Related]
27. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 1980; 645():1-54. PubMed ID: 6774485
[No Abstract] [Full Text] [Related]
28. [Galenical possibilities and problems in protraction of drug effects (author's transl)].
Müller F
Arzneimittelforschung; 1976; 26(1A):115-21. PubMed ID: 7277
[TBL] [Abstract][Full Text] [Related]
29. [Utilization of analog computers in the development of dosage forms].
Frömming KH; Lippold B; Garrett ER
Mitt Dtsch Pharm Ges Pharm Ges DDR; 1971 Sep; 41(9):205-47. PubMed ID: 4939073
[No Abstract] [Full Text] [Related]
30. Prediction of systemic availability from plasma-level data after oral drug administration.
Perrier D; Gibaldi M; Boyes RN
J Pharm Pharmacol; 1973 Mar; 25(3):256-7. PubMed ID: 4146327
[No Abstract] [Full Text] [Related]
31. Gastrointestinal absorption II. Formulation factors affecting drug bioavailability.
Blanchard J
Am J Pharm Sci Support Public Health; 1978; 150(5):132-51. PubMed ID: 364993
[No Abstract] [Full Text] [Related]
32. [Biologic availability of drugs in humans and animals].
Wichliński L
Pol Tyg Lek; 1975 Dec; 30(50):2111-2. PubMed ID: 1197106
[No Abstract] [Full Text] [Related]
33. Drug delivery systems.
Davis SS; Illum L
Practitioner; 1983 Oct; 227(1384):1537-43. PubMed ID: 6634624
[No Abstract] [Full Text] [Related]
34. Biopharmaceutics and applied pharmacy.
Krówczyński L
Pharmazie; 1971 Nov; 26(11):659. PubMed ID: 5154316
[No Abstract] [Full Text] [Related]
35. [Biopharmaceutics of drugs. Application to three tablet formulations of acetylsalicylic acid].
Cid E; Moran I
J Pharm Belg; 1975; 30(3):279-91. PubMed ID: 1206460
[No Abstract] [Full Text] [Related]
36. A model-independent proof of Dost's law of corresponding areas.
Vaughan DP
J Pharmacokinet Biopharm; 1977 Jun; 5(3):271-6. PubMed ID: 881645
[No Abstract] [Full Text] [Related]
37. Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rate.
Firsov AA; Piotrovskii VK
Pharmazie; 1986 Jun; 41(6):369-77. PubMed ID: 3763679
[No Abstract] [Full Text] [Related]
38. [Biopharmacy and pharmacokinetics].
Janků I
Pharmazie; 1971 Nov; 26(11):660. PubMed ID: 5154317
[No Abstract] [Full Text] [Related]
39. [Absorption and biological availability of drugs].
Uribe M
Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
[TBL] [Abstract][Full Text] [Related]
40. [Influence of the starting materials on bioavailability of drugs].
Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
